Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers: evidence versus wishful thinking.

D Andresen1, H C Ehlers, M Wiedemann

  • 1Department of Cardiology, Urban Hospital, Berlin, Germany.

The American Journal of Cardiology
|March 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of flow-controlled vacuum on milking performance and teat condition in a rotary milking parlor.

Journal of dairy science·2021
Same author

Towards blood flow in the virtual human: efficient self-coupling of HemeLB.

Interface focus·2020
Same author

A close shave? Performance of P2/N95 respirators in healthcare workers with facial hair: results of the BEARDS (BEnchmarking Adequate Respiratory DefenceS) study.

The Journal of hospital infection·2020
Same author

Predictors of Atrial Fibrillation Recurrence after Catheter Ablation: Data from the German Ablation Registry.

Scientific reports·2017
Same author

[Quality indicators and structural requirements for Cardiac Arrest Centers-German Resuscitation Council (GRC)].

Der Anaesthesist·2017
Same author

[Quality indicators and structural requirements for Cardiac Arrest Centers-German Resuscitation Council (GRC)].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017

Beta blockers significantly reduce cardiac death in post-myocardial infarction patients. Despite proven benefits, especially for those at risk of ventricular tachyarrhythmias, their use remains suboptimal.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Catecholamines and ischemia are key triggers for ventricular tachyarrhythmias.
  • Beta blockers counteract catecholamines and possess anti-ischemic effects.

Purpose of the Study:

  • To evaluate the continued efficacy of beta blockers in post-myocardial infarction patients, particularly in the current thrombolytic era.
  • To highlight the underutilization of beta blockers in eligible patient populations.

Main Methods:

  • Review of controlled studies from the 1980s demonstrating beta blocker efficacy.
  • Analysis of uncontrolled studies assessing beta blocker use in the thrombolytic era.
  • Examination of clinical data on beta blockers for patients with ventricular tachycardias (VTs) or ventricular fibrillation (VF).

Related Experiment Videos

Main Results:

  • Early studies confirmed beta blockers decrease sudden and nonsudden cardiac death post-myocardial infarction.
  • Uncontrolled data suggest sustained benefits of beta blockers even with modern thrombolytic therapies.
  • Beta blockers improve survival rates in patients with documented sustained VTs or VF.

Conclusions:

  • Beta blocker therapy remains a cornerstone for reducing mortality in post-myocardial infarction patients.
  • Despite strong evidence, less than 40% of eligible patients receive beta blockers in the US and Europe.
  • Beta blockers should be considered essential therapy for patients at risk of sudden cardiac death.